Insider filing · STOK
Jonathan Allan
GENERAL COUNSEL & CORP SEC
profile →
Stoke Therapeutics, Inc.
STOK · Healthcare · 33 filings in 24 months
ticker →
Jonathan Allan sold $251K of Stoke Therapeutics (STOK)
Executed Oct 3 2025, disclosed Oct 7 2025, 4 days later.
Value, as filed
$251K
10,000 sh × $25.07
Executed
Oct 3 2025
the trade date, as filed
Disclosed
Oct 7 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JAJonathan Allan (GENERAL COUNSEL & CORP SEC) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $292K of STOK (8,692 sh × $33.64, as filed), executed Mar 20.
The name
STOKHealthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jonathan Allan in STOK
STOKSALE
Stoke Therapeutics, Inc.
$292K8,692 sh × $33.64
Exec Mar 20
Filed Mar 24 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $132K
4,222 sh × $31.28
Exec Mar 18
Filed Mar 19 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $169K
5,437 sh × $31.08
Exec Dec 5 2025
Filed Dec 5 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $428K
21,267 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $206K
13,712 sh × $15.00
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $166K
12,114 sh × $13.69
Exec Dec 9 2024
Filed Dec 11 2024 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $124K
9,696 sh × $12.78
Exec Dec 6 2024
Filed Dec 10 2024 · 5:30 PM ET